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Some steroidal and non-steroidal ketone thiosemicarba-
zones 7-12, obtained from the corresponding ketones 1-6,
on oxidative cyclization with m-CPBA at OoC provide 3P-
acetoxy- 5a-cholestan-6-spiro-l ',2',4' -triazolidine- 3' -thione
13, 3P-chloro-5a-cholestan-6-spiro-l '.2',4'-triazolidine-3'-
thione 14, 5a-cholestan-6-spiro-l' ,2',4'-tfiazolidine-3'-thi-
one 15, cyclohexan-spiro-l ',2',4'-trazolidine-3'-thione 16,
bomane-2-spiro-l ',2',4'-triazolidine-3'-thion~ 17, and 5,5-
di-phenyl-l,2,4-triazolidine-3-thione 18, respectively. The
structures of these compounds have been established on
the basis of their elemental, analytical and spectral data.
1,2,4-Triazolidine-3-thiones and related
compounds have become of much interest in recent
years on account of their pharmacological
potential':". Prompted by these observations we
undertook the synthesis of some steroidal 13-15 as
well as non-steroidal 1,2,4-triazolidine-3-thiones
16-18 by the oxidative cyclization of ketone
thiosemicarbazones 7-12 with meta-
chioroperbenzoic acid (m-CPBA). Earlier Mn024,5
and H2024 had been used for the synthesis of such
compounds by the oxidative cyclization of
thiosemicarbozones but the use of m-CPBA has
provided some better results.
Thiosemicarbazone 7 on oxidative cyclization
with m-CPBA at 0° C afforded 3p-acetoxy-5a-
cholestan-6-spiro-I',2',4'-triazolidine-3'-thione 13 as
a crystalline solid, m.p. 108° C.Thiosemicarbazones
8-12 on similar treatment with m-CPBA at ooC
provided compounds 14-18, respectively in good
yields. The characterization data of compounds 13-
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Scheme I
A free-radical mechanism (Scheme II) has been
proposed for the conversion of thiosemicarbazones
to the spiro-triazolidine thiones. Here only one
isomer, in which 6NH-CS ... group is cis with
respect to 5aH, was selectively obtained which
could be explained on the basis that during
cyclization the heterocyclic ring was preferably
closed in the way that NH-CS ..... group became
equatorially (a) attached to the C-6 to avoid 1,3-
diaxial interaction due to the angular methyl group
(C 10P-CH3).
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Table I -Characterization data of compounds 7-18
Compd m.p. Yield Mol.Fonnula FOWld% (Calc.) lH NMR(CDCh)°c (%) ( S,ppm)"
C H N
7 128 95 ClOl-I51N~S 69.55 9.99 8.08 9.5(s,IH,NH),6.52(s,2H,Nlh),
(69.59 9.93 8.12) 4.7(m,IH,w'/218Hz.C3 a-H),
2.01(s,3H,OCOCH3), 1.70(m,2H,C7""H2)
8 136 92 C~)8CI 68.11 9.82 8.47 9.2(s,IH,NH),6.46(s,2H,NH2),
(68.05 9.79 8.50) 3.9(m,IH,w'/217Hz,C3 a-H),
1.73(m,2H,C7""H2)
9 112-14 88 C~N)8 73.07 10.79 9.18 8.8(s,IH,NH),6.38(s,2H,NH2),
(73.14 10.74 9.14) 1.7I(m,2H,C7""H2)
10 220 96 C7Hl~)8 49.14 7.61 24.49 8.5(s,IH,NH),6.4(s,2H,NH2)
(49.09 7.65 24.53)
11 1~8 82 CllHwN)8 58.58 8.97 18.67 9.l(s,IH,NH),6.51(s,2H,NH2)
(58.62 8.94 18.65)
12 45 86 Cldil~)8 65.63 5.13 16.35 9.I(s,IH,NH),7.3-7.05(m,lOH,aromatic),
(65.60 5.11 16.39) 6.48(s,2H,NH2)
13 108 80 ClOl-I51N~S 69.54 9.91 8.15 7.84(br,s,2H,NHCSNH),6.52(s,IH,NH),
(69.59 9.93 8.12) 4.54(m,IH, w'1218Hz,C3 a-H),
2.02(s,3H,OCOCH3), 1.68(m,2H,C7""H2)
14 115 75 C~)8CI 68.09 9.76 8.53 8.25(br,s,2H,NHCSNH), 6.8(s,IH,NH),
(68.05 9.79 8.50) 3.95(m,IH, w'1217Hz,C3a-H),
1.70(m,2H,C7""H2)
15 98-100 68 C2~)8 73.11 10.77 9.09 8.1(br,s,2H,NHCSNH), 6.72(s,IH,NH),
(73.14 10.74 9.14) 1.65(m.2H,C7""H2)
16 150 82 C7Hl~)8 49.12 7.63 24.48 8.2(br,s,2H,NHCSNH), 6.85(s,IH,NH)
(49.09 7.65 24.53)
17 102-4 72 CllHwN)8 58.61 8.96 18.66 8.5(br,s,2H,NHCSNH),6.8(s,IH,NH)
(58.62 8.94 18.65)
18 Semi- 76 Cldil~)8 65.62 5.15 16.36 8.65(br,s,2H,NHCSNH), 6.76(s,lH,NH),
solid (65.60 5.11 16.39) 7.3-7.05(m,10H,aromatic)
"Angular and side-chain methyl protons appeared at 1) 1.2..().67
H H,,-R) PMX-60 instrument (Chemical shifts in 0, ppm)
)c=/r ~ R '1 using TMSas internal standard.)C=N (-S~ Reaction of 3Jl-acetoxy-5a.-cholestan-6-ooe 1
R' HN~rR R' "<,-NH I with thiosemicarbazide. Ketone 1 (2.0 g, 4.479
1H mmoles) was taken in methanol (20 mL) and heatedto boiling. A few drops of cone. HCI were added
RX;J'
followed by thiosemicarbazide (0.416 g, 4.567
mmoles) in methanol (10 mL) with stirring. The
R' S reaction mixture was refluxed for one hr and cooled.
Scheme II The heavy precipitate thus obtained was collected
Experimental by filtration and purified by recrystallization from
All melting points reported are uacorrected methanol to give thiosemicarbazone 7 as shining
'HNMR spectra were recorded in CDCh on a Jeol needles, m.p. 128°C (Table J).
Ketones 2-6 on similar treatment with
thiosemicarbazide and after purification by
recrystallization from methanol provided
thiosemicarbazones 8-12, respectively as crystalline
solids. Their characterization data are given in
Table I.
Oxidative cyclization of thiosemicarbazone 7
with m-CPBA: 3J3-Acetoxy-Sa-cholestan-6-spiro-
1',2',4'-triazolidine-3'-thione 13. To a solution of
thiosemicarbazone 7 (1.0 g, 2.03 mmoles) in
chloroform (25 ml.), m-CPHA (0.35 g, 2.03
mriloles) was added and stirred for one hr at 0 DC.
After completion of reaction the organic layer was
separated and washed successively with aq.
NaHC03 solution (5 %), aq. Na2S203 solution (5
%) and water and dried over anhydrous sodium
sulphate. The solvents were removed under reduced
pressure. The crude product thus obtained was
purified over silica gel column (light pet. ether-ethyl
acetate, 7:1) and recrystallized from methanol to
yield compound 13 as needles. Its characterization
data are given in Table I.
3J3-Chloro-5a-cholestan-6-spiro-l ',2',4' -triazo-
lidine-3'-thione 14. Reaction of CPHA
thiosemicarbazone 8 (1.0 g, 1.93 mmoles) with m-
(0.333 g, 1.93 mmoles) at 00 C, as described above
provided compound 14 as shining crystals (Table I).
Sa-Cholestan-6-spiro-l ',2',4' -triazolidine-3'-
thione 15. Similar treatment ofthiosemicarbazone 9
(1.0 g, 2.18 mmoles) with m-CPHA (0.376 g, 2.18
mmoles) at 00 C provided compound 15 as needles
(Table I).
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Cyclohexan-spiro-l ' ,2' ,4' -triazolidine-3' -thione
16. Cyclohexanone thiosemicarbazone 10 (1.0 g,
5.84 mmoles) on similar treatment with m-CPHA.
(1.0 g, 5.84 mmoles) at 00 C provided compound 16
as crystalline solid (Table 1).
Bornane-2-spiro-l ',2' ,4'-triazolidine-3' -thione
17. Similar treatment of camphor thiosemi-
carbazone 11 (1.0 g, 4.44 mmoles) with m-CPHA
(0.766 g, 4.44 mmoles) at 00 C provided compound
17 as a crystalline solid (Table I).
5,5-Diphenyl-I ,2,4-triazolidine-3-thione 18.
Reaction of benzophenone thiosemicarbazone 12
(1.0 g, 3.9 mmoles) with m-CPHA (0.673 g, 3.9
mmoles) at 00 C as described above provided
compound 18 as a semi-solid (Table I).
Acknowledgement
We are thankful to the Head, Department of
Chemistry for providing necessary facilities and
Prof. M S Ahmad for useful discussions. Financial
support from the UGC, New Delhi in the form of
Minor Project is also acknowledged.
References
Kucukguze1I, Rollas S, & Ceuikbas A, Drug Metab Drug
Intract, 12, 1995, 151.
2 Komurcu S G, Rollas S, Yilmaz Z, & Ceuikbas A, Drug
Metab Drug In tract, 12,1995, 161.
3 Dobasz M, & Rekas S J, Acta Pol Pharm, 52, 1995, 35.
4 Islam M R, Huda Q N & Duddeck H, Indian J Chem,
29B, 1990, 376.
5 Landquist J K, J Chem Soc (C), 1971,323.
